Fanconi anemia (FA) is a rare disease characterized by congenital defects, progressive bone marrow failure and heightened cancer susceptibility. The FA proteins, BRCA1 and FANCD1/BRCA2 function cooperatively in the FA-BRCA pathway to repair damaged DNA. Activation of the FA-BRCA pathway occurs via the monoubiquitination of the FANCD2 and FANCI proteins, targeting these proteins to discrete nuclear foci where they function in DNA repair. The cellular regulation of FANCD2/I monoubiquitination, however, remains poorly understood. In this study, we have examined the roles of the p53 tumor suppressor protein, as well as its downstream target, the p21
Introduction
Fanconi anemia (FA) is a rare recessive disease characterized by developmental abnormalities, progressive bone marrow failure and elevated cancer susceptibility (Mathew, 2006; Harney et al., 2008) . There are 14 defined FA complementation groups, caused by biallelic mutations in the following genes: FANCA, FANCB, FANCC, FANCD1/BRCA2, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ/BRIP1, FANCL, FANCM, FANCN/PALB2 and FANCP/SLX4 (Moldovan and D'Andrea, 2009; Kim et al., 2011; Stoepker et al., 2011) . In addition, biallelic mutations in the RAD51C gene have recently been uncovered in a FAlike disorder (Vaz et al., 2010) . The protein products of these genes are hypothesized to function cooperatively in the FA-BRCA pathway, the primary function of which is to repair DNA damage thereby maintaining genome stability Kee and D'Andrea, 2010) . Indeed, the unifying trait of FA patient cells, as well as BRCA1/2-deficient cancer cells, is hypersensitivity to DNA crosslinking agents, for example mitomycin C (MMC) (Garcia-Higuera et al., 2001; Howlett et al., 2002) .
Upon exposure to DNA-damaging agents, and during S-phase of the cell cycle, the core FA complex, comprising FANCA, B, C, E, F, G, L, M, as well as FAAP100 and FAAP24, promotes the monoubiquitination of the FANCD2 and FANCI proteins (GarciaHiguera et al., 2001; Smogorzewska et al., 2007) . The FANCL and UBE2T proteins are the E3 ubiquitin ligase and E2 ubiquitin-conjugating enzymes, respectively (Meetei et al., 2003; Machida et al., 2006) . Monoubiquitination of FANCD2 and FANCI targets these proteins to discrete nuclear foci, where they colocalize with DNA repair and replication proteins, including BRCA1, FANCD1/BRCA2, PCNA and RAD51 (Garcia-Higuera et al., 2001; Taniguchi et al., 2002; Wang et al., 2004; Howlett et al., 2005) . Monoubiquitinated FANCD2 and FANCI are deubiquitinated by the ubiquitin-specific protease USP1 (Nijman et al., 2005) . Despite the clear importance of FANCD2/I monoubiquitination for cellular DNA crosslink repair and the molecular etiology of FA, its regulation remains poorly understood.
The p21 Cip1/Waf1 protein has a major role in the regulation of cell-cycle progression, apoptosis and cellular senescence (Abbas and Dutta, 2009) . p21 is a member of a family of cyclin-dependent kinase (CDK) inhibitors and regulates cell-cycle progression by binding CDKs via a CDK-binding domain and by binding PCNA via a PIP-box (PCNA-interaction motif) (Abukhdeir and Park, 2008; Prives and Gottifredi, 2008) . p21 inhibits DNA replication by physically blocking the interaction between PCNA and essential replication factors, for example, DNA polymerase d (Podust et al., 1995) and FEN1 (Chen et al., 1996) . p21 also forms inhibitory complexes with cyclin-CDKs thereby preventing G1-S and G2-M progression under adverse cellular conditions (Abukhdeir and Park, 2008) . The role of p21 in DNA interstrand crosslink repair remains uncharacterized.
We have recently described an important functional interaction between FANCD2 and PCNA: disruption of a FANCD2 PIP-box abrogates spontaneous and DNA damage-inducible FANCD2 monoubiquitination . In light of the strong connections between PCNA and p21, and to gain a greater understanding of the regulation of the FA-BRCA pathway, here we have analyzed the roles of the p53 and p21 proteins in the regulation of the monoubiquitination of FANCD2 and FANCI. Importantly, we demonstrate that DNA damage-inducible FANCD2 monoubiquitination is p53 independent. In contrast, the p21 protein has a major role in the regulation of the activation of the FA-BRCA pathway: p21 is required for both S-phase and DNA damage-inducible FANCD2/I monoubiquitination and nuclear foci formation. Several lines of experimental evidence demonstrate that defective FANCD2/I monoubiquitination is not a consequence of an abrogated G1-S checkpoint or altered cell-cycle progression in the absence of p21. Instead, we demonstrate that p21 is required for the transcriptional repression of the USP1 deubiquitinating enzyme upon exposure to DNA-damaging agents. In the absence of p21, persistent USP1 expression precludes the DNA damage-inducible accumulation of monoubiquitinated FANCD2 and FANCI. Furthermore, we show that defective FANCD2/I monoubiquitination can be rescued by transient expression of a p21 transgene, small interfering RNA (siRNA)-mediated USP1 knockdown and transcription inhibition. Finally, we demonstrate that p21
À/À cells display increased MMC-inducible complex chromosome aberrations and elevated gH2AX nuclear foci formation, similar to FA patient cells, establishing an important function for p21 in DNA crosslink repair. Our results indicate that p21 has a central role in the regulation of the activation of a major cellular tumor suppressor network, and suggest that p21 may have a broader role in the promotion of conservative, error-free DNA repair.
Results
The p53 tumor suppressor protein does not have an overt role in the regulation of the monoubiquitination of FANCD2 To examine the role of p53 in the activation of the FA-BRCA pathway, HCT116 p53
þ / þ and p53
À/À cells (Bunz et al., 1998) were exposed to ultraviolet-C (UV-C) irradiation, MMC and etoposide (VP-16), and FANCD2 monoubiquitination was assessed by immunoblotting. Treatment of both p53 þ / þ and p53 À/À cells with all three types of DNA-damaging agents resulted in robust activation of FANCD2 monoubiquitination: no discernible differences in the kinetics or extent of FANCD2 monoubiquitination were observed (Figures  1a and b; Supplementary Figure 1) . For example, an approximate twofold increase in the FANCD2-Ub:-FANCD2 ratio was observed 1 h following exposure to UV-C irradiation in both the p53 þ / þ and p53 À/À cells ( Figure 1a , lanes 3 and 9). Similar intact DNA damageinducible FANCD2 monoubiquitination has previously been observed in several p53-defective cancer cell lines including HeLa, MDA-MB-231, NCI-H1703, SW900 and T47D (results not shown; Garcia-Higuera et al., 2001) . Furthermore, the chicken B lymphocyte cell line DT40, which lacks functional p53, is fully competent for FANCD2 monoubiquitination (Yamazoe et al., 2004; Yamamoto et al., 2005) . These results indicate that the p53 protein does not have an overt role in the regulation of the monoubiquitination of FANCD2.
The p21
Cip/Waf1 protein is required for efficient DNA damage-inducible FANCD2 and FANCI monoubiquitination To examine the role of p21 in the activation of the FA-BRCA pathway, HCT116 p21 (Waldman et al., 1995) were exposed to UV-C irradiation, MMC and VP-16, and FANCD2 monoubiquitination was again assessed by immunoblotting. p21-dependent activation of the FA-BRCA pathway
As expected, treatment of p21 þ / þ cells with all three DNA-damaging agents resulted in robust accumulation of monoubiquitinated FANCD2. However, DNA damage-inducible FANCD2 monoubiquitination was markedly attenuated in the absence of p21 (Figure 2a ; Supplementary Figures 2a-c) . For example, an approximate twofold increase in the FANCD2-Ub:FANCD2 ratio was observed in the p21 þ / þ cells 2 h following exposure to UV-C irradiation ( Figure 2a , lane 6; Supplementary Figure 2a) . Under the same conditions, no appreciable change in the FANCD2-Ub:FANCD2 ratio was observed for the p21 À/À cells ( Figure 2a , lane 14; Supplementary Figure 2a) . Similar results were observed following exposure to MMC and VP-16 ( Supplementary Figures 2b and c) . These results strongly suggest that the p21 protein is required for the activation of the FA-BRCA pathway following cellular exposure to a wide range of DNA-damaging agents.
Several studies have demonstrated that the monoubiquitination of the FANCD2 and FANCI proteins is coupled (Sims et al., 2007; Smogorzewska et al., 2007) . For example, the monoubiquitination of the FANCI protein is dependent on the presence and monoubiquitination of FANCD2 (Sims et al., 2007; Smogorzewska et al., 2007) . Therefore, we next examined FANCI monoubiquitination in the p21 þ / þ and p21 À/À cells. As expected, in the p21 þ / þ cells, we observed a timedependent increase in monoubiquitinated FANCI following exposure to MMC (Figure 2b, lanes 2-4) . In contrast, levels of monoubiquitinated FANCI failed to increase in the p21 À/À cells following exposure to MMC (Figure 2b, lanes 6-8) .
Two approaches were taken to confirm that the observed effects were a specific consequence of the absence of p21. First, we transiently transfected the p21 À/À cells with pLenti6.2-p21, treated the cells with MMC and analyzed FANCD2 monoubiquitination by À/À clone. Once again, DNA damage-inducible FANCD2 monoubiquitination was markedly attenuated in the absence of p21 (Figure 2d , lanes 6-8). These results strongly support a specific role for p21 in promoting this post-translational modification.
To verify our findings using an alternative approach, we transiently depleted p21 protein from U2OS cells using siRNA, and assayed both spontaneous and DNA damage-inducible FANCD2 monoubiquitination. Transient p21 depletion led to an increase in basal levels of both non-ubiquitinated (42-fold) and monoubiquitinated FANCD2 (Figure 2e ). Nevertheless, similar to that observed for the HCT116 p21
À/À cells, DNA damage-inducible FANCD2 monoubiquitination was markedly attenuated upon transient depletion of p21. For example, a fourfold increase in the FANCD2-Ub:FANCD2 ratio was observed for a control non-targeting siRNA, while no appreciable increase in the FANCD2-Ub:FANCD2 ratio was observed upon p21 depletion, with very similar results being obtained for three independent p21 siRNA oligonucleotides ( Figure 2e , lanes 5 and 6, and results not shown).
Cip/Waf1 protein is required for efficient DNA damage-inducible FANCD2 nuclear foci formation Monoubiquitinated FANCD2 accumulates in discrete nuclear foci following exposure to DNA-damaging agents (Garcia-Higuera et al., 2001; Taniguchi et al., 2002; Howlett et al., 2005) . Therefore, we next examined the influence of p21 on FANCD2 nuclear foci formation. p21
þ / þ and p21 À/À cells were exposed to MMC for one cell cycle and FANCD2 nuclear foci formation was analyzed by immunocytochemistry. No differences in the number of nuclei displaying 45 discrete FANCD2 nuclear foci were observed between p21 þ / þ and p21
cells in the absence of DNA damage (Figures 3a and b) . However, the ability of FANCD2 to assemble into discrete nuclear foci following exposure to MMC was markedly attenuated in p21 À/À cells, compared with p21 þ / þ cells. For example, 16 h following exposure to 10 nM MMC, an approximate twofold increase in nuclei displaying 45 discrete FANCD2 nuclear foci was observed in p21 þ / þ cells, while no appreciable induction was observed for p21 À/À cells (Po0.0001) (Figures 3a and b) . Similar results were observed following UV-C irradiation (results not shown). We also examined the subcellular localization of FANCD2 in the p21 þ / þ and p21 À/À cells. Monoubiquitinated FANCD2 was enriched in the soluble nuclear (S2) and chromatin (S3) fractions of p21 þ / þ cells, but not p21 Figure 3c ). Nevertheless, non-ubiquitinated FANCD2 remained competent for chromatin localization in the absence of p21 (Figure 3c , lanes 9 and 12).
Chromatin localization of non-ubiquitinated FANCD2 has previously been described (Alpi et al., 2007; Howlett et al., 2009) .
The role of p21 in the regulation of FANCD2 monoubiquitination is cell-cycle independent Together with p53, the p21 protein is well known to have a major role in cell-cycle checkpoint regulation (Waldman et al., 1995; Bunz et al., 1998) . To determine if the effect of p21 on DNA damage-inducible FANCD2/I monoubiquitination was a consequence of aberrant cell-cycle progression, p21 þ / þ and p21 À/À cells were synchronized in early S-phase by double-thymidine block, released, and FANCD2 monoubiquitination was examined as cells progressed through the cell cycle. Previous studies have demonstrated that the FANCD2 protein is subject to monoubiquitination during S-phase of the cell cycle . Consistent with this study, in the p21 þ / þ cells, monoubiquitinated FANCD2 was the major isoform present upon release from double-thymidine arrest ( Figure 4a , lane 1). In contrast, double-thymidine arrest-induced FANCD2 monoubiquitination was severely impaired in the absence of p21. For example, upon release from doublethymidine arrest, an B5-fold greater FANCD2-Ub:-FANCD2 ratio was observed for the p21 þ / þ cells, compared with the p21 À/À cells ( Figure 4a , lanes 1 and 7). Pronounced differences in the FANCD2-Ub:-FANCD2 ratio between the p21 þ / þ and p21 À/À cells persisted during S-phase and throughout the cell cycle. Furthermore, for the p21 À/À cells, at no point during the cell cycle did levels of monoubiquitinated FANCD2 exceed those of non-ubiquitinated FANCD2 (Figures 4a  and b) . These results indicate that abrogated FANCD2/ I monoubiquitination is not a general consequence of irregular cell-cycle progression in the absence of p21.
Next, we examined the effects of the DNA replication inhibitors hydroxyurea (HU) and aphidicolin (APH) on FANCD2/I monoubiquitination in wild-type, p21 À/À and p53 À/À cells. HU inhibits the deoxyribonucleotide reductase enzyme leading to depletion of cellular dNTP pools, while APH is a specific inhibitor of DNA polymerase a: both agents are potent inducers of FANCD2 monoubiquitination (Howlett et al., 2005) . Similar to that observed above, robust HU-and APHinduced FANCD2/I monoubiquitination was observed for both the wild-type and p53
À/À cells. In contrast, HUand APH-induced FANCD2/I monoubiquitination was again severely attenuated in the absence of p21 (Figure 4c; Supplementary Figures 3a-c) .
p21 regulates the transcriptional repression of the USP1 deubiquitinating enzyme following exposure to DNA-damaging agents We next sought to determine if the failure to activate the monoubiquitination of FANCD2 and FANCI in the absence of p21 was a direct consequence of altered regulation of the USP1 deubiquitinating enzyme and/or the UBE2T ubiquitin-conjugating enzyme. The regulation of the FANCL E3 ubiquitin ligase in vitro could not p21-dependent activation of the FA-BRCA pathway MA Rego et al Figure 3 In the absence of p21, FANCD2 localizes to chromatin yet fails to assemble into DNA damage-inducible nuclear foci. be assessed because of the lack of a suitable commercially available antibody. p21 þ / þ and p21 À/À cells were exposed to a range of MMC concentrations for one cell cycle and USP1 and UBE2T protein expression was examined by immunoblotting. Consistent with previous observations following UV-C irradiation (Cohn et al., 2007) , we observed a dose-dependent decrease in USP1 protein levels following exposure to MMC in the p21 þ / þ cells, which correlated with the accumulation of monoubiquitinated FANCD2 (Figure 5a , lanes 1-4; Supplementary Figure 4a ). However, in contrast, in the p21 À/À cells, USP1 protein levels exhibited a dose-dependent increase following MMC exposure, coincident with a failure to activate FANCD2 monoubiquitination (Figure 5a, lanes 5-8; Supplementary Figure 4a) . Increased USP1 levels were also observed upon siR-NA-mediated p21 depletion (see Figure 2e , lanes 5 and 6). Furthermore, while basal levels of the UBE2T enzyme did not differ significantly between p21 þ / þ and p21
À/À cells, we observed a persistent and marked increase in the levels of monoubiquitinated UBE2T in the p21 À/À cells ( Figure 5a , lanes 5-8). To confirm that attenuated DNA damage-inducible FANCD2 monoubiquitination was a consequence of a failure to downregulate USP1, we depleted USP1 from the HCT116 p21 À/À cells using siRNA and examined FANCD2 monoubiquitination. Importantly, USP1 depletion led to a complete restoration of MMC-inducible FANCD2 monoubiquitination in the p21 Figure 4b ). Taken together, these results demonstrate that p21-dependent DNA damage-inducible FANCD2 monoubiquitination is mediated primarily via the regulation of the transcriptional repression of the USP1 gene.
p21
À/À cells are hypersensitive to the clastogenic effects of MMC Hypersensitivity to the clastogenic effects of DNA crosslinking agents, such as MMC, is a hallmark of FA patient cells (Auerbach, 1993) . The failure to activate both S-phase and DNA damage-inducible FANCD2/I monoubiquitination prompted us to next examine the functional role of p21 in the cellular response to DNA crosslinking agents. p21 þ / þ and p21 À/À cells were incubated in the absence and presence of 10 and 20 nM MMC for 16 h, metaphase chromosomes were prepared, and chromosome aberrations were scored. Pronounced differences in the average number of metaphase chromatid gaps and breaks and radial chromosome formations were observed between MMC-treated p21 þ / þ and p21 À/À cells. For example, a 44-fold increased frequency of chromosome aberrations was observed for p21 À/À cells compared with p21 þ / þ cells, following exposure to 20 nM MMC (P ¼ 0.003) (Figure 6a; Supplementary Figure 5) . Furthermore, these findings were corroborated using immunocytochemistry for the phosphorylated H2AX variant (gH2AX) on interphase cells. Here, we observed a 42-fold increase in nuclei harboring 410 discrete gH2AX foci for p21 À/À cells, compared with p21
cells, 24 h following exposure to 20 nM MMC (Po0.0001) (Figure 6b ). Taken together, these findings strongly support an important functional role for the p21 protein in the cellular response to DNA crosslinking agents. À/À cells were transfected with control (non-targeting) (siC), FANCD2 (siD2) and USP1 (siUSP1) siRNAs. Seventy-two hours later, cells were untreated (À) or treated ( þ ) with 40 nM MMC for 24 h, in the presence or absence of 4 mM actinomycin D (Act. D). Whole-cell lysates were prepared, and FANCD2, USP1 and a-tubulin protein expression was analyzed by immunoblotting. *Non-specific band.
Discussion
Recent reports have described an important role for monoubiquitinated FANCD2 in the recruitment of the FAN1 (for FANCD2-associated nuclease) protein to damaged chromatin, where it is thought to function in a nucleolytic step of homologous recombination DNA repair (Kratz et al., 2010; Liu et al., 2010; MacKay et al., 2010; Smogorzewska et al., 2010) . Our understanding of the cellular factors regulating FANCD2/I monoubiquitination upstream of FAN1 nucleolytic activity, however, remains largely incomplete. Inactivating mutations of any of the eight members of the core FA complex, which account for 490% of FA patients, lead to complete abrogation of FANCD2/I monoubiquitination. Additional proteins with important roles in DNA replication, including ATR, CHK1, HCLK2, PCNA and RPA, have also been demonstrated to affect DNA damage-inducible FANCD2 monoubiquitination Collis et al., 2007; Wang et al., 2007; Howlett et al., 2009 ). This is consistent with studies demonstrating an important function for the FA-BRCA pathway in the DNA replication stress response (Howlett et al., 2005; Chan et al., 2009; Naim and Rosselli, 2009) . In this study, we describe a novel role for the p21 protein in the regulation of FANCD2/I monoubiquitination that is independent of G1-to Sphase regulation. Two independently isolated HCT116 cell lines harboring homozygous deletions at the p21 locus displayed markedly attenuated S-phase and DNA damage-inducible FANCD2/I monoubiquitination and nuclear foci formation, while similarly derived HCT116 p53 À/À cells remained competent for FANCD2/I monoubiquitination. Furthermore, defective DNA damageinducible FANCD2 monoubiquitination was rescued by the transient introduction of a p21 transgene. These results argue strongly against the possibility that a coincident acquired somatic mutation is responsible for the observed phenotype. In addition, using an RNAinterference approach, p21 knockdown recapitulated the effects observed for the p21-nullizygous cells, and resulted in abrogation of DNA damage-inducible FANCD2 monoubiquitination. Interestingly, increased basal levels of non-ubiquitinated and monoubiquitinated FANCD2 were observed upon transient p21 depletion. The inhibition of cyclin-CDK activity by p21 leads to pRb hypophosphorylation and repression of E2F-mediated transcription (Abukhdeir and Park, 2008) . Previous studies in primary human keratinocytes have demonstrated that the FANCD2 gene harbors E2F transcription factor consensus sequences, and that FANCD2 protein expression can be modulated by ectopic expression of both E2F and active pRb (Hoskins et al., 2008) . Thus, the increased FANCD2 protein levels observed upon transient p21 depletion may reflect increased E2F-mediated FANCD2 expression. Similarly, over the course of these studies we have examined Fancd2 protein expression in primary p21
þ /À and p21 À/À murine embryonic fibroblasts, and could not detect appreciable levels of Fancd2 protein in primary p21 þ / þ and p21 þ /À murine embryonic fibroblasts. In contrast, robust levels of Fancd2 protein were detected in the p21 À/À murine embryonic fibroblasts, precluding a comparison of DNA damage-inducible Fancd2 monoubiquitination between these cells (results not shown). Collectively, these results suggest that p21 may have both a transcriptional and post-translational regulatory role in the FA-BRCA pathway. The increased basal levels of monoubiquitinated FANCD2 observed upon transient p21 depletion may simply be a consequence of increased total FANCD2 protein levels, or may reflect the presence of increased spontaneous DNA damage upon acute and incomplete p21 depletion. A similar observation of increased basal levels of monoubiquitinated FANCD2 yet persistent hypersensitivity to MMC has been demonstrated upon transient depletion of the CHK1 kinase (Wang et al., 2007) . Nevertheless, in both cases, the absence of p21 precluded the accumulation of monoubiquitinated FANCD2/I following cellular exposure to DNA-damaging agents.
Several lines of evidence firmly demonstrate that this newly discovered function for p21 is independent À/À cells were treated as for (a) and the number of nuclei displaying 410 discrete gH2AX foci recorded. Error bars represent standard errors of the means and all experiments were performed in triplicate with similar findings. **Po0.01; ***Po0.00.
p21-dependent activation of the FA-BRCA pathway MA Rego et al of G1-to S-phase transition, nor is it an indirect consequence of altered cell-cycle progression: First, the G1-S checkpoint is abrogated in both the p53 À/À and p21 À/À cells used in this study (Waldman et al., 1995) . However, we clearly demonstrate that DNA damageinducible FANCD2/I monoubiquitination is intact in the p53
À/À cells, yet markedly attenuated in the p21
À/À cells. p53 À/À cells express low but readily detectable levels of p21, as the p21/CDKN1A gene is also subject to p53-independent transcriptional regulation through the action of several transcription factors, including E2F1, SP1 and 3, and AP2 (reviewed in Abbas and Dutta, 2009) . Consistent with these findings, we have observed robust DNA damage-inducible FANCD2 monoubiquitination in numerous p53-defective (and G1-S checkpoint-defective) transformed cell lines including HeLa, MDA-MB-231, NCI-H1703, SW900 and T47D. Second, as a consequence of an abrogated G1-S checkpoint, asynchronous populations of p21 À/À cells, as well as p53
À/À cells, have an approximately twofold increased number of S-phase cells, compared with their wild-type counterparts (see Supplementary Figure 3a) . Previous studies have demonstrated that, even in the absence of exogenous DNA damage, FANCD2 undergoes monoubiquitination as cells traverse unperturbed S-phase . Therefore, one would expect to observe much greater levels of monoubiquitinated FANCD2 in the p21 À/À cells, simply as a function of increased S-phase progression. Again, this is clearly not what we have observed. Third, doublethymidine block-mediated cell-cycle synchronization, followed by release, revealed marked differences in the levels of monoubiquitinated FANCD2 between the p21 þ / þ and p21 À/À cells as these cells progressed through the cell cycle. Indeed, for the p21 À/À cells, at no stage throughout the cell cycle did levels of monoubiquitinated FANCD2 exceed those of non-ubiquitinated FANCD2. In addition, direct chemical inhibition of DNA synthesis with HU and APH failed to result in the accumulation of appreciable levels of monoubiquitinated FANCD2 in the absence of p21, while robust FANCD2/I monoubiquitination was observed in wildtype and p53
À/À cells. These agents are among the most potent inducers of FANCD2/I monoubiquitination Howlett et al., 2005) . Taken together, these findings demonstrate that the role of p21 in the regulation of FANCD2/I monoubiquitination is not merely a consequence of an impaired G1-to S-phase checkpoint, or altered cell-cycle progression.
Instead, we demonstrate that p21 is required for the transcriptional repression of the USP1 gene following exposure to DNA-damaging agents. The USP1 deubiquitinating enzyme undergoes autocleavage and proteasomal degradation, as well as transcriptional repression, following exposure to UV-C irradiation, thereby facilitating the accumulation of monoubiquitinated FANCD2/I (Huang et al., 2006; Cohn et al., 2007) . Consistent with these findings, we observed a dosedependent decrease in USP1 protein levels in the p21 þ / þ cells following exposure to MMC. In contrast, in the p21
À/À cells, USP1 protein levels increased under the same conditions. Similarly, the transient depletion of p21 using siRNA led to an increase in basal levels of USP1 protein. Importantly, we demonstrate that DNA damage-inducible FANCD2 monoubiquitination in the p21 À/À cells can be rescued by depleting USP1 using siRNA and by inhibiting transcription. Our results suggest that, in the absence of p21, constitutive cyclin-CDK activity leads to pRb hyperphosphorylation and elevated E2F-mediated transcriptional activation of the USP1 gene, precluding the accumulation of monoubiquitinated FANCD2/I. In addition, we also observed elevated constitutive UBE2T monoubiquitination in the absence of p21. Previous studies have established that UBE2T undergoes monoubiquitination in vivo, and that monoubiquitination inactivates UBE2T ubiquitin-conjugating activity (Machida et al., 2006) . Collectively, our results indicate that, in the absence of p21, persistent USP1 expression, and possibly constitutive inhibitory UBE2T monoubiquitination, precludes the DNA damageinducible accumulation of monoubiquitinated FANCD2/I.
Upregulation of FANCD2/I monoubiquitination occurs in response to a wide spectrum of DNAdamaging agents, as well as during S-phase of the cell cycle (Garcia-Higuera et al., 2001; Taniguchi et al., 2002; Howlett et al., 2005) . Similarly, p53-mediated transcriptional upregulation of p21 occurs following cellular exposure to DNA-damaging agents, for example ionizing radiation (el-Deiry et al., 1993 (el-Deiry et al., , 1994 Di Leonardo et al., 1994) . However, recent studies have demonstrated that the p21 protein is targeted for proteolytic degradation via CRL Cdt2 -mediated ubiquitination, following exposure to low fluences of UV irradiation (Bendjennat et al., 2003; Abbas et al., 2008; Kim et al., 2008) . Consistent with these findings, in our studies, while we generally observed robust p21 accumulation following exposure to VP-16, we did not observe significant accumulation of p21 following exposure to low doses of UV-C irradiation or MMC. Instead, we typically observed an initial decrease in p21 protein levels followed by p21 accumulation at later time points, suggesting that p21 may also be subject to ubiquitin-mediated proteolysis following exposure to DNA crosslinking agents.
In this study we also demonstrate that, like FA patient cells, p21
À/À cells demonstrate elevated levels of chromosome aberrations, including radial formations, and gH2AX nuclear foci formation following exposure to MMC, indicative of persistent unrepaired DNA strand breaks (Rogakou et al., 1998) . We propose that these observations reflect a bias toward non-conservative, error-prone DNA repair and damage avoidance pathways in the absence of p21, for example nonhomologous DNA end joining and translesion DNA synthesis. Indeed, an important role for p21 in the negative regulation of translesion DNA synthesis has recently been established (Avkin et al., 2006) . Recent studies have also firmly established that the FA proteins have a central role in preventing the promiscuous activity of non-homologous DNA end joining proteins during ICL repair (Adamo et al., 2010; Pace et al., 2010) , consistent with the long-held view that the FA pathway promotes error-free conservative homologous recombination DNA repair (Garcia-Higuera et al., 2001; Wang et al., 2004; Nakanishi et al., 2005) . The role of p21 in the regulation of non-homologous DNA end joining and homologous recombination has yet to be described.
In summary, we have uncovered a novel role for the p21 CDK inhibitor in the regulation of the monoubiquitination of FANCD2 and FANCI and in the activation of a major tumor suppressor pathway that is independent of G1-to S-phase progression. Further, we propose that p21 may have a broader role in DNA repair pathway determination following exposure to DNA crosslinking agents, a hypothesis that is currently under investigation in our laboratory.
Materials and methods
Cell culture, immunoblotting, immunocytochemistry and antibodies HCT116 and U2OS cells were grown in McCoy's 5A and Dulbecco's modied Eagle's medium media, respectively, supplemented with 12% fetal bovine serum, L-glutamine and penicillin/streptomycin. Cellular subfractionation, immunoblotting and immunocytochemistry were performed as previously described (Howlett et al., 2005 ). The following antibodies were used: rabbit polyclonal antisera against FANCD2 (NB100-182; Novus Biologicals, Littleton, CO, USA), FANCI (Dr Patrick Sung, Yale University), H2A (07-146; Millipore, Billerica, MA, USA), p21 (N-20; Santa Cruz, Santa Cruz, CA, USA), UBE2T (A301-874A; Bethyl Laboratories, Montgomery, TX, USA) and USP1 (Dr Tony Huang, New York University), and mouse monoclonal sera against a-tubulin (MS-581-PO; Lab Vision, Fremont, CA, USA), gH2AX (JBW301; Millipore) and p53 (DO-1; Santa Cruz).
Cell-cycle synchronization and analysis Cells were synchronized by double-thymidine block and cell pellets were harvested for immunoblotting and fluorescenceactivated cell sorting analysis as described previously Howlett et al., 2009) . Flow cytometric analysis was performed on a Becton Dickinson FACS Caliber instrument (San Jose, CA, USA) and cell-cycle stage distribution was determined using ModFit LT software (Verity Software House, Topsham, ME, USA).
Chromosome breakage assay Cells were treated with MMC for 16 h, and harvested for chromosome preparations as described previously (Arlt et al., 2004) . Metaphase chromosomes were analyzed using a Zeiss AxioImager.A1 upright epifluorescent microscope (Zeiss, Thornwood, NY, USA) with AxioVision LE 4.6 image acquisition software (Zeiss).
siRNA experiments Cells were plated in six-well dishes at a density of 250 000 cells per well in growth medium lacking penicillin/streptomycin. The following day, cells were transfected with 20 nM (Ambion silencer select, Invitrogen, Baltimore, MD, USA) or 200 nM (Qiagen, Valencia, CA, USA) siRNAs, using Lipofectamine 2000 (Invitrogen). Seventy-two hours post-transfection, cells were incubated in the absence or presence of MMC for a fixed period, and harvested for immunoblotting. siRNA sequences are provided in Supplementary Information.
